AIGH Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-162,547
| Closed | -$2.3M | – | 37 |
|
|
2024
Q1 | $2.3M | Sell |
162,547
-154,735
| -49% | -$2.19M | 0.69% | 28 |
|
|
2023
Q4 | $2.39M | Buy |
317,282
+184,883
| +140% | +$1.39M | 0.94% | 31 |
|
|
2023
Q3 | $1.99M | Sell |
132,399
-15,957
| -11% | -$239K | 0.94% | 31 |
|
|
2023
Q2 | $2.36M | Buy |
148,356
+28,356
| +24% | +$451K | 0.96% | 28 |
|
|
2023
Q1 | $861K | Hold |
120,000
| – | – | 0.32% | 47 |
|
|
2022
Q4 | $695K | Hold |
120,000
| – | – | 0.23% | 43 |
|
|
2022
Q3 | $1.14M | Buy |
+120,000
| New | +$1.14M | 0.35% | 34 |
|